<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Clinical Trials for Psilocybin Indicate No Adverse Effects
Image Overlay - Clinical Trials for Psilocybin Indicate No Adverse Effects

Clinical Trials for Psilocybin Indicate No Adverse Effects

January 29, 2020

Clinical Trials for Psilocybin Indicate No Adverse Effects

A phase I clinical trial conducted by researchers at King's College London and mental healthcare company Compass Pathways, indicates that the drug psilocybin has no adverse effects. Psilocybin induces hallucinogenic symptoms, which may be advantageous for some suffering from chronic depression. Yourway is able to transport even controlled substances across our global network.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 European Knowledge Forum

October 14-15, 2026
Rome, Italy

Global Clinical Trial Supply Forum Europe

October 21-22, 2026
Frankfurt, Germany

Media

Articles

When “Urgent” Isn’t Just a Word

Open chat
Come chat with us!
Hello! How can I help you?